Gone in 90 seconds

Non-melanoma skin cancers, pre-cancers, intradermal tumors and virtually any other medical or aesthetic skin condition.

All can be treated quickly and effectively with the HIFU devices from TOOsonix.

Before and After How It Works

System ONE-M

Medical device for human

oncology, dermatology

and cosmetology

System ONE-R

Laboratory device for

non-human HIFU research

and experiments

TOOsonix is a Danish medical device company committed to health innovation in the field of dermatology. Our treatments are highly accurate and more patient friendly compared to traditional methods.

100 million

Basal Cell Carcinoma
Actinic Keratosis
Diagnosed Annually

200 million

Seborrheic Keratosis
Vascular Angiomas
Diagnosed Annually

0.75 million

NF1 patients with
Cutanous Neurofibromas

Countless

Other Skin Diseases
and Conditions

Meet the experts

Joergen Serup

Professor, M.D.
Chief Physician at Dept. of Dermatology,
Bispebjerg Hospital,
Copenhagen, Denmark.

Jacek Calik

M.D, Ph.D, Oncologist
The Oncology Clinic, Old Town Clinic,
Wroclaw, Poland.

TOOsonix exhibits a world’s-first at Children’s Tumor Foundation World Conference

June 11, 2024

TOOsonix awarded MDR CE-marking

May 29, 2024

Plenary talk at Childrens Tumor Foundation World Conference 2024

May 13, 2024

See more news

TOOsonix products and technology are patent protected:

US11494351B2; US11679283B2; EP3589367B1, CN109890463B. Other patents pending.

ISO 13485:2016 certified since 2018